• CNS effects: cognitive slowing ("dopa-topamax"), word-finding difficulty, memory problems, somnolence, dizziness
• Metabolic: weight loss, decreased appetite, metabolic acidosis (carbonic anhydrase inhibition)
• Renal: nephrolithiasis (kidney stones) - also from CA inhibition
• Ophthalmologic: acute angle-closure glaucoma (rare but serious, early onset)
• Teratogenicity: oral clefts in neonates

Topiramate Side Effects

Mechanism Overview

1. Cognitive / CNS Effects (most common reason for discontinuation)

• Cognitive slowing - impaired cognitive processing, often without sedation or mood change (distinctive among antiseizure drugs)
• Dysnomia - difficulty with expressive language, word-finding, and name recall
• Diminished verbal fluency and verbal memory
• Dose-dependent: incidence reaches 26% at 400 mg/day; some patients are unaffected even at higher doses
• Somnolence, fatigue, dizziness, nervousness, and confusion (especially in first 4 weeks)
• Emotional lability and mood changes

Clinicians typically start low (25-50 mg/day) and titrate slowly to minimize cognitive effects.

• Katzung's Basic and Clinical Pharmacology, 16th ed.

2. Sensory Effects

• Paresthesias - the most common side effect; typically perioral (around the mouth); often occurs at initiation or with dose increases and may resolve with continued treatment
• Impaired taste (dysgeusia / taste perversion)

3. Ophthalmologic - URGENT

• Acute myopia + angle-closure glaucoma: rare but serious; typically occurs within the first month of treatment. Requires prompt drug withdrawal.
• Patients should report any change in visual acuity immediately.

4. Renal / Urologic

• Nephrolithiasis (kidney stones): occurs in 0.5-1.5% of patients on long-term therapy; more common in men. Caused by CA inhibition reducing urinary citrate and increasing urinary pH.
• Patients with a history of kidney stones should maintain adequate fluid intake. Avoid combining with other CA inhibitors (e.g., zonisamide, acetazolamide).

5. Metabolic

• Metabolic acidosis: hyperchloremic, non-anion gap type; due to CA inhibition reducing bicarbonate reabsorption. Usually asymptomatic but may cause fatigue, anorexia, nausea/vomiting. Long-term implications for bone health are unclear.
• Weight loss: seen in ~85% of adults on long-term therapy; averages ~5% of baseline body weight; peaks at 12-18 months. Can be therapeutic in obesity (phentermine/topiramate ER = Qsymia) but unintended in epilepsy patients.
• Beneficial secondary effects with weight loss: improved lipid profile, glycemic control, and blood pressure.

6. Thermoregulatory

• Oligohidrosis / hypohidrosis (decreased sweating) with hyperthermia: occurs mainly in children during hot weather. Risk of heat stroke - monitor carefully.

7. Teratogenicity

• Oral cleft formation (cleft lip/palate): data in humans show a 16-21-fold increased relative risk with first-trimester exposure.
• Topiramate is contraindicated or requires careful counseling in pregnancy.

8. Other / Drug Interactions

• Enzyme-inducing drugs (e.g., carbamazepine, phenytoin) reduce topiramate's half-life from 20-30 hours to 12-15 hours.
• Dry mouth, insomnia, and constipation (especially with phentermine/topiramate combination).
• Increased levels in renal failure and hepatic impairment - dose adjustment required.

Quick Reference Summary Table

Topiramate: Allergic Reactions & Rashes

1. Mild Allergic Reaction

• Mild skin rash, itching
• These still require a call to your doctor - topiramate should be discontinued at the first sign of any rash unless it is clearly non-drug-related

2. Serious Skin Reactions - Stop Drug Immediately

Stevens-Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN)

• Blistering, peeling, or loosening of skin
• Red/purple skin lesions, often with a purple center
• Red, irritated eyes
• Sores or ulcers in the mouth or on the lips
• Fever, chills, sore throat, joint pain

If signs suggest SJS/TEN, do not resume topiramate - switch to alternative therapy. - Mayo Clinic

3. Anaphylaxis / Angioedema - Emergency

• Rash with swelling of the face, eyes, lips, or tongue
• Hoarseness, difficulty breathing or swallowing
• Swelling of hands or mouth

4. DRESS Syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms)

• Widespread rash + fever + swollen lymph nodes
• Unusual bruising or bleeding, unusual fatigue
• Yellowing of skin or eyes (liver involvement)
• Chest pain, painful urination (kidney involvement)

5. Multi-Organ Hypersensitivity (without rash)

• Fever, frequent infections
• Severe muscle pain
• Enlarged liver/spleen (pain in upper abdomen)

Key Rule of Thumb